Close

Articles Posted in Pharmaceutical Litigation

Updated:

Generic Drug Companies Held to Lower Standard Than Name Brand Counterparts – U.S. Supreme Court Rules in Pliva v. Mensing

Federal preemption has long been a hot button issue in pharmaceutical drug cases, with consumer advocates arguing that drug companies should be held to the sometimes higher state standards. However, the U.S. Supreme Court appears to have reversed the federal preemption stance it took in Wyeth v. Levine. In Wyeth,…

Updated:

Contaminated Heparin Lawsuit Awarded 625,000 By Cook County Jury – Johansen v. Baxter International

The first case to go to trial in the series of Cook County pharmaceutical negligence lawsuits against Baxter International received a $625,000 verdict against the pharmaceutical manufacturer. The Illinois lawsuit of Estate of Johansen v. Baxter International, Inc., et al., 09 L 11175, was filed after the plaintiff, Steven Johansen,…

Updated:

FDA Okays Abbott’s Marketing of Trilipix as Combo Medication

The Food and Drug Administration (FDA) voted to allow Trilipix, a cholesterol lowering medication, to continue to be marketed as a drug that can prevent heart attacks. The approval comes despite government studies showing that there were no substantial changes in incidences of heart attacks in patients taking Trilipix in…

Updated:

Prescription Drug Liability Case Receives 21 Million Verdict – Bartlett v. Mutual Pharmaceutical Co., Inc.

A New Hampshire jury awarded the state’s highest product liability verdict ever when it awarded Karen Bartlett $21 million for the injuries she incurred as a result of taking Sulindac, an anti-inflammatory prescription drug manufactured by Mutual Pharmaceutical Co., Inc. The jury found the drug company liable for Bartlett’s injuries…

Updated:

Illinois Pharmacy’s Duty to Warn Customers of Drug Interactions Examined By Illinois Appellate Court – DiGiovanni v. Albertson’s, Inc.

A recent Illinois Appellate Court case reviewed what a drug store’s duty is to its customers regarding possible drug interactions in an Illinois pharmaceutical lawsuit. In DiGiovanni v. Albertson’s, Inc., No. 04 L 3580, the decedent’s estate alleged that the pharmacy had a duty to warn the decedent about a…

Updated:

Johnson & Johnson Drug Recall Update: Pharmaceutical Company Not Cooperating According to Oversight Committee

The U.S. House Committee on Oversight and Reform are accusing Johnson & Johnson of being uncooperative, providing false information, and employing delay tactics during its interactions with the House Committee. The congressional investigation launched on May 27, 2010 against Johnson & Johnson, was done so in response to widespread drug…

Updated:

GlaxoSmithKline Avandia Case Settles: First of Many Cases Set For Trial

The first Avandia case set for trial against drug manufacturer GlaxoSmithKline (GSK) settled for an undisclosed amount. The pharmaceutical litigation case was brought against GSK after new studies of Avandia revealed that using the drug could increase the risk of heart attacks and strokes. No details of the settlement or…

Updated:

Recall of Children’s Tylenol Subject of Congressional Hearing Entitled “Johnson & Johnson’s Recall of Children’s Tylenol and Other Pediatric Medicines”

Yesterday the House Committee on Oversight and Government Reform Johnson & Johnson’s Recall of Children’s Tylenol and Other Pediatric Medicines” in order to further investigate McNeil Consumer Healthcare/Johnson & Johnson’s recall of numerous children’s medicines. Since its April 10, 2010 voluntary recall, Johnson & Johnson has recalled around 136 million…

Updated:

Alli and Xenical (Orlistat) Could Cause Severe Liver Injury: FDA Warns of Dangers of Weight Loss Drug

Yet another weight loss drug has been accused of posing a safety risk due to its potential causing of liver damage or failure. Yesterday the U.S. Food and Drug Administration (FDA) completed its safety review of the the weight loss drug Orlistat, which has been marketed under the names of…

Updated:

Children’s Tylenol Recalled By FDA

The U.S. Food and Drug Administration (FDA) announced what could amount to a nationwide recall of children’s Tylenol and dozens of other over-the-counter medicines. The FDA conducted an inspection at a McNeil drug plant in Pennsylvania that has resulted in the recall of more than 40 varieties of liquid pediatric…

Contact Us